The global blood clot retrieval devices market has been witnessing a significant growth in the recent years. Blood clot retrieval devices are medical retrieval devices used by interventional radiologists and vascular neurologists to remove blood clots from arteries in the brain. A rise in the number of strokes and increased adoption of minimally invasive endovascular treatments for acute ischemic stroke have been the key factors driving the demand for blood clot retrieval devices. Additionally, technological advancements leading to better efficacy and outcomes of these devices have further supported their adoption. However, high costs associated with these devices and lack of reimbursement policies in some regions continue to restrain the market growth to some extent.
Market Dynamics:
Rise in the geriatric population who are more prone to strokes, increasing incidence of strokes worldwide, as well as preference for minimally invasive surgeries are some of the major factors driving the growth of the global blood clot retrieval devices market. According to recent data, ischemic strokes account for around 87% of all strokes cases. On the other hand, high costs of these technologically advanced devices, lack of reimbursement policies, and dearth of skilled professionals are challenging the market expansion. Moreover, the development of newer generation devices with superior functionalities is further creating growth opportunities for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global blood clot retrieval devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood clot retrieval devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic, Teleflex Incorporated, Penumbra, Inc., AngioDynamics, Johnson and Johnson, and Abbott Laboratories
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood clot retrieval devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood clot retrieval devices market
Detailed Segmentation-
- By Stroke
- Ischemic Stroke
- Hemorrhagic Stroke
- Pulmonary Embolism
- Deep Vein Thrombosis
- Transient Ischemic Attack
- Others
- By Device
- Mechanical Embolus Removal Devices
- Penumbra Blood Clot Retrieval Devices
- Stent Retrievers
- Aspiration Device
- Ultrasound Assisted Device
- By Application
-
- Coronary Arteries
- Peripheral Arteries
- Cerebral Arteries
- By End User
-
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- By Region:
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
-
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson
- Boston Scientific Corporation
- Penumbra, Inc.
- Terumo Corporation
- Edwards Lifesciences Corporation
- Argon Medical Devices, Inc.
- Cook Medical Inc.
- Control Medical Technology
- Acandis GmbH
- Phenox GmbH
- Braun Melsungen AG
- Teleflex Incorporated
- MicroVention, Inc.
- Merit Medical Systems
- L. Gore & Associates, Inc.
- Inari Medical, Inc.